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The network theory of immune responsiveness, as originally proposed by Jerne (1), 
suggests  that  recognition  of unique  determinants  on  immunoglobulins  by  other 
antibodies results in self-regulation of antibody production. To explain the apparent 
idiotype specific restrictions of T-T and T-B cell collaboration the network theory has 
been expanded to encompass the interaction of lymphoid cells as well as antibodies 
(2-14). Thus, interaction of target cells with T-helper (2-5)  or T  suppressor  (5-14) 
cells may depend on recognition of unique idiotypic determinants on the surface of 
the  target  cell.  Furthermore,  these  interactions  may  be  mediated  by  regulatory 
molecules that either bear the idiotype themselves (10, 15-18) or are idiotype specific 
(10). 
In most studies of idiotype-specific suppression of a B cell response, suppressor cells 
have been induced by administration of anti-idiotypic antiserum (7,  10,  19), idiotype 
alone (4, 20), or idiotype conjugated to syngeneic cells (9). The operation of such an 
idiotypic suppressor  mechanism  during  the  normal  course  of a  humoral  immune 
response would be more directly demonstrated  if antigen-induced suppressor cells, 
acting in an idiotype-specific manner, could be elicited by antigen. We have, therefore, 
used  a  model  of immune  suppression  involving hapten-coupled  syngeneic cells  to 
study  suppressor  T  lymphocytes acting  in  an  idiotype-specific fashion  to  depress 
plaque-forming-cell (PFC) 1 responses. 
Previously, we have reported that the intravenous injection of spleen cells covalently 
coupled with the 4-hydroxy-3-nitrophenyl acetyl (NP) hapten induces T cell-mediated 
suppression of a hapten-specific delayed-type hypersensitivity (DTH) response in mice 
of the Igl b allotype (12-14). In the present work, we have extended these findings to 
a  B  cell  system.  Thus,  spleen  cells  from  mice  treated  7  d  previously  with  NP- 
conjugated syngeneic spleen cells are capable of selectively suppressing the expression 
of idiotype-positive B  cells either when  transferred to normal  recipients in  vivo or 
* Supported by grants AI-14732 and AI-00152 from the National Institutes of Health and by grant 
PCM 80-04573 from the National Science  Foundation. 
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when  subcultured  for a  4-d period and  then  added to NP-primed cultures in  vitro. 
Furthermore,  the suppression is T  cell dependent  because treatment with anti-Thy- 
1.2 antiserum +  complement C  ablates the transfer of nonresponsiveness both in vivo 
and  in  vitro.  Purified T  cells are capable of transferring  this  idiotype-specific sup- 
pression. The data support the network hypothesis of T-B cell interaction via idiotypic 
recognition because antigen-induced T  suppressor cells selectively affect the respon- 
siveness of idiotype-bearing B  cell clones. 
Materials  and  Methods 
Mice.  C57BL/6 male, CBA/J male, and BALB/cJ female mice were purchased from The 
Jackson Laboratory, Bar Harbor, Maine. BALB/c nu/nu  mice were a  gift of Dr.  L. Perry, 
Department of Pathology, Harvard Medical School, Boston, Mass. All experimental animals 
were between 8  and  12 wk of of age at the beginning of immunization. Animals were age- 
matched in each experiment. 
Antigens.  NP-poly-(L-Glu~-L-LysaS-L-AIa  1°)  (GLA),  NP-poly-(L-OluSa-L-LysaS-L-Phe  a) 
(GL~), NP-keyhole limpet hemocyanin (KLH), and NP-Ficoll were conjugated by the reaction 
of NP-O-succinimide  (Biosearch,  San  Rafael,  Calif.)  with  GLA  (prepared  by  E.  Blout  of 
Harvard Medical School), GL~  (lot GLP1-71-199;  Miles-Yeda Ltd., Rehovot, Israel), KLH 
(Sigma Chemical Co., St. Louis, Mo.), or AECMTS-Ficoll (Biosearch) as described previously 
(21). The NP-GLA and NP-GLth had an average of 7 and 6 hapten groups per carrier molecule 
respectively. The NP-KLH and NP-Ficoll had an average of 30 and 17 NP groups/100,000 mol 
wt, respectively. Dextran  (B1355S  linkages) was kindly provided by Dr. R.  Riblet (The Fox 
Chase Institute for Cancer Research, Philadelphia, Pa.). 
Immunization.  Mice were immunized with  150 #g NP-KLH i.p. or 70 #g i.p. NP-GLA in a 
0.2 ml mixture that contained 25% pertussis vaccine (Michigan Department of Public Health, 
Lansing, Mich.), with 25 #g NP-Ficoll, or with 50 #g dextran in 0.2 ml saline. 
Haptenated Cell Preparation.  NP-coupled spleen cells were made as described previously (14). 
Briefly, single-cell suspensions were treated with Tris-NH4CI to lyse erythrocytes. After two 
washes, the cells were resuspended in phosphate-buffered saline (PBS), pH  7.6,  and reacted 
with 2.5raM NP-O-succinimide in dimethylsulfoxide for 3 min. The reaction was stopped with 
minimum essential medium  (MEM)  containing  1.2 mg/ml glyeylglycine. Cells were washed 
extensively in MEM before injection of 2 ×  107-3 ×  107 NP-coupled cells i.v. into syngeneic 
recipients. 
Anti-Thy-l.2 Treatment.  2 ×  108-3 ×  10  s spleen cells from NP-coupled-cell-treated mice were 
pelleted and incubated in  1.0 ml of a  1:5 dilution of AKR anti-C3H thymocyte serum or in 
normal  mouse serum  (NMS)  as control.  After 30  min  at  20°C,  the cells were washed  and 
resuspended in 1.0 ml rabbit C diluted 1:5 in MEM that containing 1% DNase. After a 30-min 
incubation at 37 °  cells were washed in MEM and 2-3 ×  107 viable cells were transferred to 
normal recipients. For in vitro studies, the treatment was carried out under sterile conditions 
using 0.3 ml AKR anti-C3H thymocyte serum diluted 1:5 and 0.3 ml diluted rabbit complement 
for every 2 ×  10  7 cells recovered from 4-d subcultures. 
Anti-NP b Antiserum.  Anti-idiotypic antiserum specific for the NP  b idiotype was prepared as 
described previously (12). Briefly, guinea pigs were injected biweekly every 2 wk with 200 #g of 
affinity-purified C57BL/6 anti-NP antibodies, obtained from a pool of primary sera from mice 
immunized with NP-bovine gammaglobulin. 2 wk after the third injection, animals were bled 
and the antisera extensively adsorbed with immunoadsorbents conjugated with MOPC  104E 
~,~), and (C57BL/6 X DBA/2) normal mouse gammaglobulin. The specificity of this reagent 
has been determined by an inhibition of idiotype-binding assay (22).  30 #l of normal mouse 
sera, MOPC 104E, 30 #l C3H anti-NP sets, and 1.25 X 10  -4 M dinitrophenyl caproate did not 
inhibit  idiotype binding.  However  1.0 #l  of primary B6  anti-NP sera, 4.25  ×  l0  -6 M  NP- 
caproate or 2.0  ×  10  -6 M  (4-hydroxy-5-iodo-3-nitrophenyl)acetyl (NIP)-caproate could effi- 
ciently inhibit idiotype binding. The gammaglobulin fraction of this anti-idiotypic antiserum 
was  prepared by 40%  (NH4)2SO4  fractionation, followed by extensive dialysis against PBS. 
Normal guinea pig gammaglobulin was similarly prepared. 
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control or NP-coupled spleen cells were teased into a single cell suspension and 3 ×  10  v cells 
were injected i.v. into normal syngeneic recipients. Recipients were  then immunized with 25 
pg NP-Ficoll in saline or 70 pg NP-GLA in 25% pertussis vaccine. Direct  (IgM) splenic NP- 
specific PFC responses were assayed  5 d after immunization  with NP-Ficoll and indirect (IgG) 
splenic NP-specific  PFC responses were assayed 10 d after immunization  with NP-GLA. For in 
vitro studies,  spleen cells from control mice or mice treated 7 d  previously with NP-coupled 
spleen cells were teased and washed under sterile conditions. These cells were added to Linbro 
culture wells (Linbro Chemical Co., Hamden, Conn.) at a concentration of 7.5 ×  106 cells/ml 
per well in Mishell-Dutton culture medium that contained 10% fetal  calf serum (lot  95045; 
Microbio!ogical Associates, Walkersville, Md.) (23). Cultures were incubated at 37°C in a  10% 
CO2 atmosphere in rocking culture boxes and fed daily with 0.1 ml supplementary medium for 
a  4-d  subculture period.  Cells  were  then  pooled,  washed,  and  5  ×  105  viable normal or 
suppressor cells were added to 7.5 ×  106 NP-primed cells. 
Pur~'cation of T Cells.  The method of Mage et al. (24) was used to purify splenic T  cells. 
Purified rabbit anti-mouse immunoglobulin  (5 ml of 1 mg/ml solution) was added to  100- × 
15-mm polystyrene petri plates (1005; Falcon Labware, Div., Becton, Dickinson & Co., Oxnard, 
Calif.) and incubated for  1 h at room temperature. Unbound antibody was washed off and 8 
×  10  7 spleen cells were  added for a  1-h incubation period at 20°C. The nonadherent T  cell 
population was  recovered  by gentle swirling. Less  than  2.0% of these  cells  stained with  a 
fluorescent rabbit anti-mouse immunoglobulin  antiserum. 
In  Vitro Cultures.  C57BL/6  mice were  immunized with  150 pg  NP-KLH  i.p.  with  25% 
pertussis vaccine. 4 wk later, their spleens were removed and teased into a single-cell suspension 
under sterile conditions. Cells were washed and resuspended in Mishell-Dutton media that 
contained 10% fetal calf serum.  7.5  X  106 was added to each well  of Linbro culture plates 
viable NP-primed cells. Cultures were challenged with 100 ng NP-GL~ or NP-Ficoll in 20 pl. 
A  primry sheep erythroeyte (SRBC)  response was  obtained by addition of 2  ×  106 washed 
SRBC to culture wells that contained 7.5  ×  l0  s normal, unprimed spleen cells. All cultures 
were incubated in rocking boxes at 37°C in a  10% CO2 atmosphere and were fed daily with 0.1 
ml supplementary medium. 5 d after challenge, duplicate wells were  pooled and assayed  for 
total NP- or SRBC-specific PFC responses on replicate slides. 
PFC Assay.  NP-  or  SRBC-specific PFC  were  assayed  by  the  Dresser  and Greaves  (25) 
modification of the plaque assay ofJerne et al. (26). NP-conjugated SRBC were prepared as 
follows. 2 ml of washed and packed SRBC was resuspended in 8 ml of borate-buffered saline, 
pH 8.8. NP-O-succinimide (20 mg in 2.0 ml dimethylformamide) was added dropwise.  After a 
10-min incubation period, the reaction was stopped by addition of cold PBS that contained 1.2 
mg/ml glycylglycine. The cells were washed extensively in PBS before use.  Dextran SRBC 
were prepared by coupling palmitoyl-derivatized dextran (a gift of Dr. R. Riblet) with washed 
SRBC as described previously (27). A goat anti-mouse IgM (lot 41073; Gateway Immunosera 
Co., Kankakee, Ill.) was used at a  1:400 dilution to inhibit IgM PFC for assay of indirect PFC. 
Npb-bearing PFC were  inhibited from  forming plaques by the  addition of 3.0-4.0 /~1  anti- 
idiotypic reagent  to  each  slide  at  the  beginning of  the  assay.  The  control  response  was 
determined by addition of 3.0-4.0 p.l normal guinea pig gammaglobulin.  The percent inhibition 
of PFC was calculated according to the formula: 
(  experimental PFC.~ 
percent inhibition --  1 -  control PFC  ,] ×  100%. 
Slides were incubated at 45°C for  1 h. A 1:20 dilution of lyophilized guinea pig C (Pei-Freeze 
Biologicals Inc., Rogers, Ark.) was then added for an additional 1-h incubation period. Indirect 
or total PFC were developed with a  1:250 dilution of rabbit anti-mouse anti-IgG antiserum. 
Results 
Specificity  of Guinea  Pig Anti-NP n Antiserum.  Mice of the  Igh-1 b allotype produce 
antibody that  bears  the  NP  b  idiotype  after  immunization with  NP-coupled  com- 
pounds (28, 29). To determine if idiotype-secreting B cells can be specifically inhibited 
with anti-idiotypic  antibody in a plaque assay system, C57BL/6 mice were immunized SHERR, JU,  WEINBERGER,  BENACERRAF,  AND  DORF  643 
with  NP-GLA or NP-Ficoll. 5  d  after immunization  with  NP-Ficoll and  10  d  after 
immunization with NP-GLA, the ability of anti-NP  b antibodies to inhibit direct (NP- 
Ficoll) or indirect (NP-GLA) PFC responses was assayed. The data in Table I indicate 
that  -50%  of the primary NP-specific B  cells induced with  NP-GLA and NP-Ficoll- 
can  be  inhibited  from  forming plaques  with  anti-idiotypic antiserum.  3  #1  of anti- 
idiotypic seemed to give plateau levels of inhibition, because increasing the amount 
of anti-idiotype to  10 #1 did not increase the percentage of inhibition (Table I). The 
data suggest that a  significant fraction of NP-specific B  cells in C57BL/6  mice bear 
the NP  b idiotype. To show the antigen specificity of the anti-idiotype serum, spleen 
cells  from  mice  immunized  with  SRBC  were  assayed  in  the  presence  of anti-NP  b 
idiotype. Under  the conditions employed, no  inhibition of SRBC-specific PFC  was 
detected (Table I). Because mice that do not bear the Igh-1 b allotype do not express 
Npb-bearing NP-specific antibodies, it would be predicted that PFC from NP-primed 
BALB/c  (Igl a)  or CBA/J  (Igl  j)  mice would  not  be  inhibitable with  anti-idiotypic 
antiserum.  The results (Table I)  support  this prediction because the addition of 3.0 
#1 anti-NP  b antiserum to spleen cells from BALB/c or CBA/J  mice primed with NP- 
Ficoll  did  not  inhibit  plaque  formation.  Because  the  antibody  response  to  NP 
compounds  has  been  shown  to  consist  predominantly  of light  (X)  -chain  bearing 
molecules in mice of the Igh-1 b allotype (29), the apparent antigen or strain specificity 
of the putative anti-NP  b antiserum  could  be a  result  of anti-X-chain  reactivity. To 
exclude this possibility, BALB/c mice were immunized with 50 #g dextran B 1355S. 
The immune response of BALB/c mice to this antigen consists primarily of X-chain- 
bearing  antibodies  (30).  5  d  later, the ability of the anti-NP  b antiserum  to  inhibit 
TABLE  I 
Specificity  of PFC Inhibition  with Guinea Pig Anti-NP n Antiserum * 
Percent inhibition 
Strain  Antigen (mice/  with anti-NP  h ±  Specific anti-NP 
SE:~  PFC/spleen X+ 
group)  log SE§ 
3.0 lal  10 lal 
C57BL/6  NP-GLA (4)  57 ± 6  --  17,600 X+ 1.2 
C57BL/6  NP-Ficoll (9)  50 ± 6  49 ± 3  14,500  ~  1.1 
C57BL/6  SRBC (3)  -3 ±  13  --  39,300 X+ 1.5 
CBA  NP-Ficoll (3)  -5 ± 5  --  7,600 X+ 1.7 
BALB/c  NP-Ficoll (12)  7 ± 8  --  34,400 X+ 1.3 
BALB/c  Dextran  (3)  7 ± 9  --  36,800 X+ 1.7 
BALB/c  NP-Ficoll (3)  --  --  33,600 x+ 1.7 
(nu/nu) 
* C57BL/6,  CBA, BALB/c, or BALB/c (nu/nu)  mice were immunized  with 
70 lag NP-GLA, in pertussis vaccine, 25 tag NP-Ficoll, 0.2 ml of 10% SRBC 
or 50 lag dextran (B1355S). NP- or dextran-specific IgM PFC were assayed 
5 d after immunization  with  NP-Ficoll or dextran.  NP- or SRBC-specific 
IgG PFC were assayed 10 d after immunization with NP-GLA or SRBC. 
:[: The percent idiotype-positive response is expressed as the arithmetic means 
± SE of the percent inhibition of plaque formation in the presence of 3.0 or 
10 lal anti-NP  b antiserum  relative to the response in the presence of normal 
guinea pig IgG. 
§ The magnitude of the response is expressed as the geometric mean ×/+ log 
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dextran-specific PFC  formation was  tested. The inability of anti-NP  b antiserum  to 
affect this response (Table I) further demonstrated its idiotype specificity. Thus, this 
guinea pig antiserum detects an idiotypic determinant present on NP-specific PFC 
from  C57BL/6  mice  that  corresponds  to  the  NP  b idiotype described  in  previous 
serological studies (28, 29). 
To evaluate the requirement for the presence of a thymus or conventional thymus- 
derived lymphocytes for the in vivo NP-Ficoll response, athymic BALB/c nu/nu mice 
were immunized with 25 #g NP-FicoI1. After 5 d, the PFC responses were assayed. As 
shown in Table I, the responses of BALB/c nu/nu mice were of  comparable magnitude 
to those of conventional BALB/c mice. In  contrast,  BALB/c nu/nu  mice produce 
fewer than 2,000 NP-specific PFC/spleen to the antigen NP-GLA (data not shown). 
T  Cell-mediated, Idiotype-specific Suppression of NP-GLA  and  NP-Ficoll  Responses In 
Vivo.  We have previously reported that  the  intravenous injection of NP-modified 
spleen cells induces T  lymphocytes that are capable of suppressing the DTH response 
to NP  (12-14). To determine if this treatment can induce suppressor ceils that  can 
specifically affect PFC responses, C57BL/6 mice were given an injection of 3 ×  107 
control or NP-conjugated spleen cells i.v.  7 d  later 3  ×  107 spleen cells from these 
donors were transferred to  normal  syngeneic recipients.  Recipients and  remaining 
donor groups were then immunized and their splenic IgM  (NP-Ficoll) or IgG (NP- 
GLA) PFC responses assayed 5 or 10 d  later for the magnitude of the response and 
the percent Npb-bearing B cells.  It can be seen (Table II) that control mice produced 
between 54 and 45% idiotype-positive PFC after immunization with NP-GLA or NP- 
Ficoll as determined by plaque inhibition with anti-NP  b antiserum. However, plaques 
from mice injected intravenously with NP-spleen cells were not inhibitable with anti- 
idiotype under identical assay conditions. The suppression of idiotype-positive B cells 
could be transferred to normal recipients with 3  ×  107 spleen cells from suppressed 
donors.  Although  the  magnitude  of the  response  may  decrease  concurrently,  as 
demonstrated by mice immunized with NP-GLA, a significant decrease in the number 
of PFC  is  not  required  to  manifest  suppression  of idiotype-positive clones.  Thus, 
although the percent idiotype-positive B cells dropped from 50 to 6% in NP-Ficoll- 
immunized  recipients of suppressor cells,  the  magnitude  of the  response was  only 
marginally affected. It may be concluded then that idiotype-specific suppressor cells 
induced with hapten-modified syngeneic cells specifically suppress the NP  b idiotype- 
positive clones while leaving the responsiveness of Npb-idiotype-negative clones un- 
affected. The specificity of this suppressor mechanism is further demonstrated by the 
inability of treatment with NP-coupled spleen cells to reduce a  SRBC PFC response 
(Table II). 
To determine if T  cells are required to transfer idiotype-specific suppression, spleen 
cells from mice injected 7 d previously with NP-coupled syngeneic cells were treated 
with NMS or anti-Thy-l.2 serum +  C before transfer to normal recipients. Recipients 
were immunized either with  NP-GLA or NP-Ficoll as indicated  in  Table III.  The 
data again confirm that although ~40% of the PFC response was inhibited with anti- 
idiotypic  antiserum,  the  PFC  response  of mice  that  had  received  NMS-treated 
suppressor cells was not inhibitable with anti-NP  b antiserum. Treatment of cells with 
anti-Thy-l.2  serum  +  C  completely ablated  the  ability  of these  cells  to  transfer 
idiotype-specific suppression  to  normal  recipients.  Thy-l.2-positive cells,  therefore, 
appear necessary to transfer idiotype-specific  suppression. Surprisingly, after treatment SHERR,  JU,  WEINBERGER,  BENACERRAF, AND DORF 
TAaLE  II 
Idiotype-specific Suppression of B Cell Responses In  Vivo  * 
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Antigen 
Spleen 
cells 
Tolerogen (donor  trans-  Percent inhibi- 
ferred  tion with anti- 
mice/group)  (recipient  NP  b antiserum:~ 
mice/ 
group) 
Specific PFC/spleen x+ log SE§ 
Anti-NP  Anti-SRBC 
NP-GLA 
NP-Ficoll 
SRBC 
Control (7)  --  54 ±  6  9,800 X+ 1.3  -- 
NP-spleen (7)  --  1 ±  1211  3,800 X+ t.3~l  -- 
Control  3 X  10  7 (1 1)  36 ±  8  15,700 X+ 1.2  -- 
NP-spleen  3 ×  107 (12)  --16 ±  1111  5,400 X+ 1.211  -- 
Control (4)  --  45 +  11  7,300 X+ 1.3  -- 
NP-spleen (4)  --  --18 ±  1011  4,200 X+ 1.2  -- 
Control  3 ×  I07 (9)  50 ±  10  l t,too X+ 1.1  -- 
NP-spleen  3 ×  107 (8)  6 ±  511  8,7OO x+ 1.2  -- 
Control (7)  --  --  --  12,600 x+ 1.2 
NP-spleen (7)  --  --  --  15,200 +x 1.2 
* 7 d after the injection of 3 X  10  7 syngeneic  control or NP-coupled spleen cells i.v., 3 X  107 spleen  cells 
from C57BL/6 mice were transferred to normal syngeneic recipients.  Donor and recipient mice were then 
immunized with 70 pg NP-GLA in pertussis vaccine, 25 ~g NP-Ficoll, or SRBC. 10 (NP-GLA and SRBC) 
or 7 (NP-Ficoll)  d later, their spleens were assayed  for magnitude and percent idiotype-positive IgG or 
IgM PFC responses, respectively. 
~: The percent idiotype-positive response is expressed as the arithmetic mean :1: SE of the percent inhibition 
of the PFC response in the presence of 4.0 ~1 anti-NP  ~ antiserum, relative to the response in the presence 
of normal guinea pig IgG. 
§ The magnitude of the response is expressed as the geometric mean ×/+ log SE. 
l] Significant decrease  in the response relative to controls,  P <  0.007. 
¶ Significant decrease  in the response relative to controls,  P <  0.05. 
with anti-Thy-1.2 antiserum  +  C, the magnitude  of the NP-specific PFC response did 
not  return  to  control  levels,  even  though  the  percentage  of idiotype-bearing  PFC 
corresponded  to  control  values.  These  data  add  support  to  the  contention  that 
nonresponsiveness  is mediated  by idiotype-specific suppressor  T  cells. 
To  determine  if T  cells are  sufficient  for transfer  of idiotype-specific suppression, 
spleen  cells from  mice treated  7  d  previously with  NP-conjugated  cells were  passed 
over  rabbit  anti-mouse  immunoglobulin-coated  plates  before  transfer  to  normal 
recipients.  The  ability  of  these  purified  T  cells  to  transfer  significant  idiotype 
suppression  (Table  III)  indicates  that  T  cells  are  both  required  and  sufficient  to 
mediate  immune  suppression. 
T  Cell-mediated,  Idiotype-specific  Suppression of the PFC Response In  Vitro.  An  in  vitro 
secondary assay system using NP-KLH-primed  spleen cells challenged with NP-Ficoll 
or NP-GI~  was used to confirm the activity of idiotype-specific suppressor T  cells on 
B  cell responses. To induce suppressor cells, C57BL/6  mice were injected with 3  ×  107 
NP-coupled  spleen cells i.v.  7  d  later,  spleen  cells from control  or NP-spleen  treated 
mice were cultured  in  Linbro wells. After a  4-d subculture  priod,  5  ×  105 control or 
suppressor  cells were  added  to  hapten-primed  spleen  cell cultures  and  the  cultures 646  IDIOTYPE-SPECIFIC  SUPPRESSION  OF  PLAQUE-FORMING  CELLS 
TABL~  III 
T  Cell-mediated  Transfer of NP  n Idiotype-specific Suppression In  Vivo * 
Percent inhibi-  NP-specific PFC/ 
Tolerogen (mice/  Treatment of trans-  tion with anti-  spleen +X log SE§ 
Antigen  group)  ferred cells  NP  b antiserum:~ 
NP-GLA  Control (5)  NMS +  C  39 ±  15  23,800 X+ 1.1 
NP-spleen (4)  NMS +  C  -16 ±  28  7,200 x._. 1.1¶ 
NP-spleen (4)  Anti-Thy-l.2 +  C  51 ±  5  11,900 X+ 1.1¶ 
NP-Ficoll 
NP-Ficoll 
Control (5)  NMS +  C  43 +  9  13,600 X  1.1 
NP-spleen (4)  NMS +  C  9 ±  8[[  9,000 X+ 1.2 
NP-spleen (4)  Anti-Thy-l.2 +  C  46 +  4  7,100 x+ 1.1¶ 
Control (4)  Control  62 +  5  15,400 X+ 1.1 
NP-spleen (4)  Purified T  cells  19 ±  1411  5,800 x+ 1.3¶ 
* 7 d  after the injection of 3  ×  l0  7 syngeneic control  or  NP-coupled spleen cells i.v., spleen cells from 
C57BL/6 mice were either treated with NMS +  C or anti-Thy-l.2 +  C, or were passed over rabbit anti- 
mouse immunoglobulin-coated plates  to  purify T  cells.  2  ×  10  7  viable cells were  then transferred  to 
normal syngeneic recipients.  10 d  after immunization with NP-GLA and  7 d  after immunization with 
NP-Ficoll, recipient mice were assayed for splenic IgG and IgM PFC responses, respectively. 
:~ The percent idiotype-positive response is expressed as the arithmetic mean +  SE of the percent inhibition 
of the PFC response in the presence of 4.0 pl anti-NP  b antiserum relative to the response in the presence 
of normal guinea pig IgG. 
§ The magnitude of the response is expressed as the geometric mean ×/+  log SE. 
[1 Significant decrease in the response relative to controls, P <  0.04. 
¶ Significant decrease in the response relative to controls, P <  0.01. 
were challenged with NP-GI-4b or NP-Ficoll. The results presented in Table IV clearly 
show that cells obtained from idiotype suppressed donors were capable of significantly 
suppressing the magnitude of an in vitro response to NP-Ficoll and to NP-GI~. This 
suppression was antigen specific because the magnitude of a primary SRBC response 
remained unaltered.  In  addition,  anti-Thy-l.2 +  C  treatment  of these cells signifi- 
cantly  depleted  their  ability  to  suppress  these  responses.  The  data  obtained  for 
idiotype-bearing clones may be similarly interpreted. Although the control response 
to NP-Ficoll or to NP-GI_~ consisted of 86-100% idiotype-bearing PFC, the response 
of cultures to which 5 ×  105 suppressor cells had been added was composed exclusively 
of idiotype-negative populations.  Anti-Thy-l.2  +  C  treatment  of suppressor  cells 
allowed the expression of idiotype-positive PFC. The suppression appeared specific in 
these in vitro studies because the SRBC response was not inhibited. Furthermore, the 
specificity of the anti-idiotype was demonstrated, as this reagent did not significantly 
decrease the number of SRBC-specific PFC. 
Discussion 
To  assay  for  idiotype-specific  suppression  of a  B  cell  response,  a  guinea  pig 
antiserum raised against anti-NP antibodies purified from C57BL/6 mice was used to 
inhibit NP-specific plaque formation. This antiserum was judged idiotype specific by 
virtue of its ability to inhibit  NP-specific plaque formation up to 57%  in  vivo and 
100% in vitro with microliter quantitites without affecting SRBC-specific PFC from 
C57BL/6 mice. In addition, it appeared that this anti-idiotypic antiserum recognized Antigen 
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TABLE  IV 
T Cell-dependent NP  b Idiotype-specific Suppression In  Vitro* 
Percent inhibi-  Specific PFC/culture x+ log 
Treatment of cells  tion with anti-  SE§ 
Donor treatment  added to cultures  NP  h antiserum 
±  SE:[:  Anti-NP  Anti-SRBC 
NP-Ficoll 
NP-GLO 
SRBC 
Control  --  86 +  4  3,090 ~  1.2  -- 
NP-spleen  NMS + C  7 ± 41  740 X+ 1.8[  I  __ 
NP-spleen  Anti-Thy-l.2 +  C  100 ± 0  1,870 X+ 1.7  -- 
Control  --  91 ±  6  1,770 X+ 1.4  -- 
NP-spleen  NMS +  C  0  40 X 3.6[  I  __ 
NP-spleen  Anti-Thy-l.2 + C  64 ±  36  1,600 X+ 2.0  -- 
Control  --  3  920 
NP-spleen  --  --  910 
* C57BL/6 mice received an injection of 3 ×  107 control or NP spleens i.v. 7 d later, spleens were teased, 
and  cultured  at  7.5  ×  106 cells/ml in  Linbro culture wells. After a  4-d subculture  period,  cells were 
washed,  treated as indicated, and added to duplicate wells that contained  7.5 ×  106 responder spleen 
cells from mice immunized 4 wk previously  with NP-KLH. The cultures were then challenged with 100 
#g NP-Ficoll or NP-GL~. For an SRBC-specific  response, 2 ×  106 washed SRBC were added to 7.5 ×  10  6 
normal spleen cell responders.  5 d after antigenic challenge, duplicate wells were pooled and assayed  for 
total NP- or SRBC-specific  PFC responses. 
:~ Results are expressed as the arithmetic mean +  SE of the percent inhibition of the PFC response in the 
presence  of 4.0 #1 anti-NP  b antiserum relative to the response  in the presence  of 4.0 #1 guinea pig IgG. 
The idiotype-positive  responses  of suppressed  cultures challenged with NP-GI_~  and  control cultures 
challenged with SRBC were obtained in single experiments.  All other data were pooled from two or three 
experiments.  Only cultures containing >600 specific PFC were assayed for inhibition with anti-idiotypic 
antiserum. 
§ Background PFC were subtracted from the PFC response  in cultures that contained antigen to obtain 
specific PFC. Data are expressed as the geometric mean X/+ log SE of three or more experiments. 
H  Significant decrease in response relative to controls,  P <  0.02. 
the  NP  b idiotype as  described  in  serologic studies  (28,  29)  because  it  inhibited  anti- 
NP  PFC  only  from  mice  possessing  the  Igh-1 b  allotype  (Table  I).  Although  the 
mechanism  of plaque inhibition is not certain, it is possible that  binding of idiotype- 
bearing surface receptors by anti-idiotype prevents secretion of antibody.  This mech- 
anism has been proposed in other systems  (11,  31). Alternatively, inhibition of plaque 
formation  may  be  manifest  by  direct  binding  of anti-idiotype  to  antibody  as  it  is 
secreted  from B  cells. 
In this paper the ability of T  suppressor  cells induced by the intravenous adminis- 
tration  of NP-modified  syngeneic  cells  to  reduce  an  idiotypic  B  cell  response  was 
studied  in  both  an  in  vivo and  an  in  vitro system.  In  previous  studies,  it  has  been 
shown  that  the  intravenous  injection  of NP-modified  syngeneic  cells induces  T  cell 
populations capable of suppressing  a  DTH  response to the NP haptenic determinant 
in C57BL/6  mice (12-14).  At least  two interacting subpopulations  have been identi- 
fied.  The  induction-phase  suppressors,  thus  termed  because  of their  activity  when 
transferred  before  immuniztion  with  NP,  bind  antigen,  bear  the  NP b  idiotype,  and 
are capable  of suppressing  an  NIP  response  in  mice of the  Igh-1 b allotype.  The  fine 
specificity  of these  suppressors  appears  analogous  to  the  specificity  patterns  of the 
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the interpretation that this suppressor cell population bears an NP  b idiotypic receptor 
(28,  29, 32, 33). It also appears that these induction-phase suppressor cells induce a 
second population of cells in the presence of antigen, called effector-phase suppressors, 
that  acts on the effector limb of the DTH response and  neither binds  antigen nor 
bears the NP  b idiotype. Effector-phase suppressors have an anti-idiotypic receptor and 
are restricted by Igh-V and H-2 region genes (13,  14). 
Our experiments did not address the question of which population(s) of suppressor 
T cells mediate the suppression of the PFC response. In contrast to the in vivo studies, 
spleen cells from mice treated  7 d  previously with  NP-coupled spleen cells do not 
cause significant levels of suppression when added directly to in vitro cultures (data 
not shown). The requirement for a 4-d subculture period may reflect the induction of 
a  second  population  of T  cells  involved  in  a  suppressor  pathway  similar  to  that 
induced in the NP-specific DTH system. Subculturing is also required to demonstrate 
suppression  in  other systems  (34).  Perhaps  this  procedure increases  the  activity or 
numbers of effector cells.  Preliminary data indicating that  subcultured spleen cells 
from NP-spleen treated mice can suppress an effector phase NP response in vitro (data 
not shown) is consistent with the concept that effector cells have been induced during 
this  subculture  period.  Recruitment  of effector cells  in  vivo may be envisioned to 
occur  in  recipients  of cells  from  NP-spleen-treated  donors.  Furthermore,  because 
suppression of the PFC response is idiotype specific, it appears that the effector-phase 
suppressor population has an anti-idiotypic receptor. Experiments are in progress to 
determine which suppressor T  cell subset is directly responsible for idiotype-specific 
suppression and to distinguish idiotype-specific suppressor cells from idiotype-specific 
cytolytic T  lymphocytes. 
The cellular target of the suppressor cells is most likely an Npb-idiotype-bearing B 
cell. Because NP-induced suppressor cells are unable to nonspecifically reduce SRBC 
responses in vivo or in vitro, it may be concluded that the suppression is NP specific. 
Furthermore,  the  presence  of GLA-specific T  cell  help  in  vivo suggests  that  any 
decrease in the NP-specific response will be a result of suppression at the B cell level. 
This conclusion is supported by the results obtained after immunization or challenge 
with NP-Ficoll both in vivo and in vitro. Thus, as Ficoll is a relatively T-independent 
carrier (35,  36 and Table I), suppression of any fraction of the NP-Ficoll response 
probably reflects a  decrease in the activity of the NP-specific B cell population.  It 
appears, then, that T  suppressor cells generated after treatment with NP-derivatized 
spleen cells specifically recognize idiotype-bearing B cells. However, we cannot exclude 
the  possibility  that  the  target  of the  suppressor  cell  is  a  regulatory  T  cell  which 
specifically helps Npb-bearing B cell clones. Such idiotype-bearing T  helper cells have 
been described elsewhere (2-4). Alternatively, an idiotype-bearing suppressor cell may 
interfere with T  helper cells that bear anti-idiotypic receptors. 
In  the  vivo  studies,  spleen  cells  from  NP-spleen-treated  mice  were  capable  of 
suppressing idiotype-positive B  cells essentially  100% after immunization with  NP- 
GLA. Reduction of the magnitude of the response to ~50% of control levels may then 
reflect the  functional elimination  of all  of the  NP-specific cells that  bear the  NP  b 
idiotype. Therefore, suppression appears to affect a specific idiotypic population and 
does not  alter the responsiveness of Npb-negative clones. Interestingly, whereas the 
idiotypic B cell response to NP-Ficoll is eliminated almost completely by the transfer 
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Because control mice still express 50% idiotype-positive B cells, the marginal decrease 
in the magnitude is probably not a  result of a  lower percentage of idiotype-bearing 
cells but rather may represent a reconstitution of the NP response by idiotype-negative 
clones. These results may be contrasted with those obtained in the NP-specific DTH 
system in which  induction  phase suppressor T  cells eliminate essentially all  of the 
response induced by priming with  NP-BGG and challenge with either NP-BSA or 
NIP-BSA. The effectiveness of inducer suppressor cells in the DTH system may be a 
result  of the  predominantly  idiotypic  nature  of the  NP-specific  DTH  response. 
Idiotypic  suppressor  cells  are  thereby  capable  of affecting  the  entire  NP-specific 
response. 
The in vivo data demonstrate that  T  suppressor cells can selectively eliminate a 
major subpopulation of B cells carrying the predominant idiotype. A similar argument 
can be made for the data generated in vitro.  Thus, the greater degree of suppression of 
the magnitude of response to NP-GI.4b (98%) or to NP-Ficoll (76%) may be attributed 
to the increased percentage of idiotype-positive clones (91  and 86%, respectively) in 
control responses. This increase in idiotype-bearing cells may either be a consequence 
of the culture conditions employed or may be a  characteristic of the response after 
priming and challenge with NP on different carriers. The latter hypothesis may be 
contrasted  with  previous  studies  which  indicate  that  in  hyperimmune  mice  the 
concentration of NP  b idiotype is reduced (29). However, in earlier studies, the assay 
used to determine idiotype content was highly affinity dependent and therefore may 
not have accurately reflected the number of Npb-idiotype-bearing molecules (29). The 
ability of suppressor cells to decrease the T  dependent, NP-specific response by 98% 
after challenge with NP-GI.4b may also reflect the suppression of NP-specific helper T 
cells. These hapten-specific helper cells may be generated in NP-KLH-primed mice 
and their activity observed under the present culture conditions. In support of this 
contention is the fact that the NP-GI.~ responses may be obtained in these experiments 
with cells from mice generally incapable of providing Gl_zh-specific T  cell help (37). 
Because in most  investigations of immune suppression the idiotypic specificity is 
not  evaluated,  it  is  possible  that  the  antigen-specific  suppression  reported  may 
represent modulation of responsiveness by a population of idiotype-specific suppressor 
cells instead of suppressor cells capable of recognizing unique antigenic determinants. 
When  an antigen capable of eliciting a  relatively heterogenous response is used  to 
induce suppression, a series of idiotype-specific suppressor cells may be generated. It 
should be noted in this regard that the ability to demonstrate suppressive activity by 
transfer of nonresponsiveness to normal or reconstituted recipients may then depend 
on the presence of.idiotypic determinants common to both the donors and recipients 
of suppressor cells. Evidence for such Igh-restricted suppressor cells has been generated 
in some systems (5-9). The possibility that such T-T or T-B cell interactions occur 
under normal physiologic conditions is more strongly supported by the demonstration 
that  naturally occurring  (38)  or antigen-induced  (11)  suppressor cells are  idiotype 
specific. The data presented in this report and that of Alevy and Bellone (11) extend 
these  findings  to  well-defined  hapten  systems  in  which  B  cell  responsiveness  is 
suppressed. Because in the present studies, suppressor cells are generated with hapten 
coupled onto syngeneic cells, the results may more accurately represent physiologic 
suppressor mechanisms  responsible for hyporesponsiveness to antigens  presented in 
the context of self components. Thus, further study of the idiotype-restricted interac- 650  IDIOTYPE-SPECIFIC  SUPPRESSION  OF PLAQUE-FORMING  CELLS 
tions of lymphocytes in the NP-modified-spleen-cell  system may elucidate  naturally 
occurring mechanisms of self-tolerance. 
Summary 
The  ability  of suppressor  cells  induced  by  the  intravenous  administration  of 4- 
hydroxy-3-nitrophenyl acetyl (NP)-modified syngeneic cells to reduce an idiotypic B 
cell response was studied in both an in vivo and an in vitro system. Idiotype-positive 
B cells were assayed by the ability of guinea pig anti-idiotypic antiserum to specifically 
inhibit  idiotype-positive plaque  formation.  It was found that  up to 57% of the PFC 
response  in  vivo and  100% of the  PFC  response  in  vitro was  inhibitable  with  anti- 
idiotypic antiserum.  The expression  of these  idiotype-positive  B  cells  could be sup- 
pressed  by  the  transfer  of spleen  cells  from  mice  treated  7  d  previously with  NP- 
coupled  syngeneic cells.  T  cells  are  both  required  and  sufficient  for the  transfer  of 
idiotype specific  suppression.  The  induction  of these  idiotype-specific  T  suppressor 
cells  directly with  antigen  suggests  that  recognition  of unique  determinants  on cell 
surfaces is important for regulation of lymphoid cell interactions. The role of idiotype- 
specific suppressor cells in the network of lymphoid interactions is discussed. 
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